Prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trial
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trial
Authors
Keywords
-
Journal
LANCET ONCOLOGY
Volume 22, Issue 9, Pages 1240-1249
Publisher
Elsevier BV
Online
2021-08-13
DOI
10.1016/s1470-2045(21)00348-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MRI-Targeted or Standard Biopsy in Prostate Cancer Screening
- (2021) Martin Eklund et al. NEW ENGLAND JOURNAL OF MEDICINE
- MRI-Targeted, Systematic, and Combined Biopsy for Prostate Cancer Diagnosis
- (2020) Michael Ahdoot et al. NEW ENGLAND JOURNAL OF MEDICINE
- The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma
- (2020) Geert J.L.H. van Leenders et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Clinical utility and cost modelling of the phi test to triage referrals into image-based diagnostic services for suspected prostate cancer: the PRIM (Phi to RefIne Mri) study
- (2020) Lois Kim et al. BMC Medicine
- Does a novel diagnostic pathway including blood-based risk prediction and MRI-targeted biopsies outperform prostate cancer screening using prostate-specific antigen and systematic prostate biopsies? - protocol of the randomised study STHLM3MRI
- (2019) Tobias Nordström et al. BMJ Open
- Combining prostate health index and multiparametric magnetic resonance imaging in the diagnosis of clinically significant prostate cancer in an Asian population
- (2019) Po-Fan Hsieh et al. WORLD JOURNAL OF UROLOGY
- The Stockholm-3 Model for Prostate Cancer Detection: Algorithm Update, Biomarker Contribution, and Reflex Test Potential
- (2018) Peter Ström et al. EUROPEAN UROLOGY
- Prostate Cancer Diagnostics Using a Combination of the Stockholm3 Blood Test and Multiparametric Magnetic Resonance Imaging
- (2018) Henrik Grönberg et al. EUROPEAN UROLOGY
- NCCN Guidelines Updates: Prostate Cancer and Prostate Cancer Early Detection
- (2018) Peter H. Carroll et al. Journal of the National Comprehensive Cancer Network
- MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis
- (2018) Veeru Kasivisvanathan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Optimizing patient's selection for prostate biopsy: A single institution experience with multi-parametric MRI and the 4Kscore test for the detection of aggressive prostate cancer
- (2018) Sanoj Punnen et al. PLoS One
- Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study
- (2018) Olivier Rouvière et al. LANCET ONCOLOGY
- Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculator for Initial Prostate Biopsy by Incorporating the 2014 International Society of Urological Pathology Gleason Grading and Cribriform growth
- (2017) Monique J. Roobol et al. EUROPEAN UROLOGY
- EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent
- (2017) Nicolas Mottet et al. EUROPEAN UROLOGY
- International Society of Urological Pathology (ISUP) grading of prostate cancer - An ISUP consensus on contemporary grading
- (2016) Lars Egevad et al. APMIS
- Prostate Health Index improves multivariable risk prediction of aggressive prostate cancer
- (2016) Stacy Loeb et al. BJU INTERNATIONAL
- A calibration hierarchy for risk models was defined: from utopia to empirical data
- (2016) Ben Van Calster et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- An Approach Using PSA Levels of 1.5 ng/mL as the Cutoff for Prostate Cancer Screening in Primary Care
- (2016) E. David Crawford et al. UROLOGY
- The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma
- (2015) Jonathan I. Epstein et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Comparison Between the Four-kallikrein Panel and Prostate Health Index for Predicting Prostate Cancer
- (2015) Tobias Nordström et al. EUROPEAN UROLOGY
- Comparison of MR/Ultrasound Fusion–Guided Biopsy With Ultrasound-Guided Biopsy for the Diagnosis of Prostate Cancer
- (2015) M. Minhaj Siddiqui et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Predicting High-Grade Cancer at Ten-Core Prostate Biopsy Using Four Kallikrein Markers Measured in Blood in the ProtecT Study
- (2015) Richard J. Bryant et al. JNCI-Journal of the National Cancer Institute
- Prostate cancer screening in men aged 50–69 years (STHLM3): a prospective population-based diagnostic study
- (2015) Henrik Grönberg et al. LANCET ONCOLOGY
- Predicting High-Grade Cancer at Ten-Core Prostate Biopsy Using Four Kallikrein Markers Measured in Blood in the ProtecT Study
- (2015) Richard J. Bryant et al. JNCI-Journal of the National Cancer Institute
- SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials
- (2013) An-Wen Chan et al. ANNALS OF INTERNAL MEDICINE
- Urinary PCA3 as a Predictor of Prostate Cancer in a Cohort of 3,073 Men Undergoing Initial Prostate Biopsy
- (2013) K. Kent Chevli et al. JOURNAL OF UROLOGY
- Prostate-Cancer Mortality at 11 Years of Follow-up
- (2012) Fritz H. Schröder et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started